"Japanese equities have underperformed developed market benchmarks in 2021, in part due to what felt, at times, like an inordinately fraught response to the pandemic. Of course, every nation’s response could be fairly described as fraught at one point or another, but Japan’s vaccine campaign was slow by the standards of rich nations and there are lingering questions about the economy."